Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2012
11/27/2012US8318132 Imaging agents for detecting neurological dysfunction
11/27/2012US8317718 Methods of testing digestive functions using both a breath test and a scintigraphy test, and methods of using a breath test as an overall digestive health assessment
11/22/2012WO2012156511A1 Bombesin receptor targeting peptide incorporating a 1, 2, 3-triazole group in the backbone for preparing in vivo diagnostic and therapeutic agents
11/22/2012US20120294803 Cxcr4 antagonists for imaging of cancer and inflammatory disorders
11/22/2012US20120294802 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/22/2012US20120294801 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
11/22/2012US20120294800 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
11/22/2012US20120294799 Anti-tem1 antibodies and uses thereof
11/22/2012US20120294798 Methods of treating cancer using il-21
11/22/2012US20120294797 Anti-cgrp compositions and use thereof
11/22/2012US20120294796 Antibodies Reactive with B7-H3 and Uses Thereof
11/21/2012CN102791296A Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites
11/21/2012CN101723850B Novel 18F labeled aromatic amino acids, preparation method and application thereof in tumor imaging
11/21/2012CN101723849B Novel 18F labeled amino acid derivatives, preparation method and application thereof in tumor imaging
11/21/2012CN101648028B Vitamin-targeted imaging agents
11/20/2012US8313758 Method of producing high alcohol content foaming compositions with silicone-based surfactants
11/20/2012US8313728 Vitamin-targeted imaging agents
11/20/2012US8313521 Method of delivering an implantable medical device with a bioabsorbable coating
11/20/2012CA2633171C Antibodies against tumor-associated antigenic target (tat) polypeptides
11/20/2012CA2608919C Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
11/15/2012WO2012154894A2 Integrin receptor antagonists and their methods of use
11/15/2012WO2012153254A1 Pretargeting kit for imaging or therapy comprising a trans - cyclooctene dienophile and a diene
11/15/2012US20120288445 Radiolabelling
11/15/2012US20120288444 Single diastereomers of 4-fluoroglutamine and methods of their preparation and use
11/15/2012US20120288443 Labelled pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their use in diagnostic methods
11/15/2012US20120288442 Nuclear Imaging Method Using Molecular Target Detection Agent for Liver Fibrosis
11/15/2012US20120288441 Injectable biodegradable particles
11/15/2012CA2835298A1 Pretargeting kit for imaging or therapy comprising a trans - cyclooctene dienophile and a diene
11/15/2012CA2835214A1 Integrin receptor antagonists and their methods of use
11/14/2012EP2522369A1 Pretargeting kit, method and agents used therein
11/14/2012EP2522366A1 Targeting agent for tumor site
11/14/2012CN1960707B Liposomal assembly for therapeutic and/or diagnostic use
11/14/2012CN102772809A Nano magnetic control agglomeration chemotherapeutic pharmaceutical composition and preparation method thereof
11/14/2012CN102126985B 18F labelled precursor compound and preparation method and application thereof
11/13/2012US8309609 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
11/13/2012US8309355 Methods of treating Parkinson's disease using viral vectors
11/13/2012US8309111 High alcohol content foaming compositions with silicone-based surfactants
11/13/2012US8309055 PET radiotracers
11/13/2012US8309054 Method for the purification of radiolabelled compounds
11/13/2012US8309053 Labeled fatty acid analogs; tissue-targeted therapy; tomography; block the catabolic pathway, thus trapping these analogs in a virtually unmodified form in the tissues of interest such as heart, liver, or tumor; endo-vinylic variants of cycloalkyl-substituted heptadecanoic acid for example
11/13/2012CA2478414C Selective targeting of tumor vasculature using antibody molecules
11/08/2012WO2012151199A1 Ultrafiltration concentration of allotype selected antibodies for small-volume administration
11/08/2012WO2012150715A1 Novel 11c labeling compound, method for producing same, and use of same
11/08/2012WO2012150220A1 Radiolabeled amino acids for diagnostic imaging
11/08/2012WO2012149644A1 Novel agonists and antagonists of the urotensinergic system
11/08/2012US20120283195 Glycopeptide phosphonate derivatives
11/08/2012US20120282180 Compounds with Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof
11/08/2012US20120282179 Methods of Using C-Met Modulators
11/08/2012US20120282178 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
11/08/2012US20120282177 ROR1 as Therapeutic and Diagnostic Target
11/08/2012US20120282176 Method and Constructs for the pH Dependent Passage of the Blood-brain-barrier
11/08/2012US20120282175 Methods for Increasing Efficacy of FOLR1 Cancer Therapy
11/08/2012US20120282174 Synergistic Anti-CD47 Therapy for Hematologic Cancers
11/08/2012US20120282173 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
11/08/2012US20120282172 Targeted delivery to human diseases and disorders
11/08/2012US20120282171 Radiolabelling methods
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012US20120282169 Detection and treatment of traumatic brain injury
11/08/2012US20120282168 Methods of sensitizing cancer to therapy-induced cytotoxicity
11/08/2012US20120282167 Method for predicting the sensitivity of a tumor to an epigenetic treatment
11/08/2012CA2835015A1 Radiolabeled amino acids for diagnostic imaging
11/08/2012CA2832464A1 Novel agonists and antagonists of the urotensinergic system
11/07/2012CN102770163A Iodine radiolabelling method
11/07/2012CN102770162A Vesicular formulations
11/07/2012CN102206306B Tumor-targeted carrier material as well as preparation method and application thereof
11/06/2012US8303960 Radiolabeled affibody molecules
11/06/2012US8303935 Alkoxy substituted imidazo[1,2-a]pyridines having affinity for amyloid
11/06/2012US8303934 Methods and compositions of [32P]-labeled adenine nucleotides for the treatment of atherosclerosis, vascular arterial diseases and coronary artery diseases
11/06/2012US8303933 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/06/2012US8303932 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/06/2012US8303931 Multimodal imaging using a three compartment polymer nanoparticle with cell specificity
11/01/2012WO2012147978A1 β-1, 3-1, 6 GLUCAN LABELED BY STABLE ISOTOPE 2H AND/OR STABLE ISOTOPE 13C, PROBE USING SAME, AND PRODUCTION METHOD THEREFOR
11/01/2012WO2012147115A1 Automatic device for the synthesis of peptide-based radioactive drugs for diagnostic and/or therapeutic use
11/01/2012US20120277517 Formulation and Methods for Enhanced Interventional Image-Guided Therapy of Cancer
11/01/2012US20120276586 Desmosterol-producing yeast strains and uses thereof
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276007 Imaging agents and methods of imaging naaladase or psma
11/01/2012US20120276006 Contrast agents for myocardial perfusion imaging
11/01/2012US20120276005 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
11/01/2012US20120276004 Human myeloid derived suppressor cell cancer markers
11/01/2012US20120276003 Compound containing an oxygen-15, preparation and use thereof, and composition comprising thereof
11/01/2012US20120276002 Contrast agent for optical imaging, use thereof and apparatus using the same
11/01/2012US20120276001 Bifunctional polyazamacrocyclic chelating agents
11/01/2012US20120276000 Clec14a inhibitors
11/01/2012US20120275999 Oncolytic rhabdovirus
11/01/2012US20120275998 Biodegradable stent comprising an acid scavenging agent
11/01/2012US20120275997 Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2833608A1 Automatic device for the synthesis of peptide-based radioactive drugs for diagnostic and/or therapeutic use
10/2012
10/31/2012EP2518086A1 Radiolabeled compound directable in vivo to target tissue and use thereof
10/31/2012EP2517732A1 Transnasal labeling composition for tissues of central nervous system, and labeling method and screening method each using the transnasal labeling composition for tissues of central nervous system
10/31/2012EP2517730A2 Vitamin receptor binding drug delivery conjugates
10/31/2012EP2517729A2 Vitamin receptor binding drug delivery conjugates
10/31/2012EP2515949A1 Aldehydes for in vivo imaging of aldh in cancer stem cells
10/31/2012EP2515948A1 Formulations suitable for pet imaging with hydrophobic pet agents
10/31/2012EP2515650A1 Targeted radiolabeled compounds and their use for the treatment and diagnosis of cancer
10/31/2012CN102762230A Novel radioimmunoconjugates and uses thereof
10/31/2012CN102762229A Formulations suitable for pet imaging with hydrophobic pet agents
10/31/2012CN102757017A Oxygen isotope-containing compound, preparation method and application and composition
10/31/2012CN101972478B 抗体治疗 Antibody therapy
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 243